Current and Future Landscape in Genetic Therapies for Leber Hereditary Optic Neuropathy pubmed.ncbi.nlm.nih.gov/37566092/ Fantastic paper by Hoda - very proud! Well done 👏

Age-related macular degeneration: suitability of optogenetic therapy for geographic atrophy Frontiers - Neuroscience A great team effort Hoda Shamsnajafabadi 👁️🧠, Benjamin W.J. Ng, Kanmin Xue, Samantha de Silva, Susan M. Downes, MacLaren Research Group Oxford, Jasmina Kapetanovic frontiersin.org/journals/neuro…

Oxford Ophthalmology Congress 2024 #OOC2024 with amazing Doyne Lecture by Robert MacLaren MacLaren Research Group Oxford, Hertford college gala dinner and so excited to share our research on optogenetic gene therapy on retinal human organoid.

Fantastic day at CRISPR workshop in Merton college.Great talks on CRISPR editing, activation and clinical applications.

Fabio Benfenati, the winners of the prestigious "Italian Nobel" prize 2024. Very proud to had the opportunity working in Fabio lab during my PHD.

#OptoGRC 2024 (Lucca, Italy), interesting talk on Optogenetics, neural manipulation and complex behaviour.

#OptoGRC2024, great talk by Botond Roska on restoration of vision using Optogenetics in clinical application of Optogenetics session. Very exited to present my poster on Optogenetic gene therapy validation on human retinal organoids.

An incredible time at Optogenetics Gordon Research Conference conference, filled with insightful discussions, innovative ideas and dynamic networking. Proud to be part of such a talented and forward-thinking community. #OptoGRC2024

Excited to share my latest article on CRISPR-Cas mediated base editing approaches for CRB1-related retinal dystrophy! A must-read for anyone passionate about base editing gene therapy of retinal disease! Jasmina Kapetanovic MacLaren Research Group Oxford mdpi.com/2073-4425/15/5…

Excited to share our last publication on “Genetic therapies and potential therapeutic applications of CRISPR activators in the eye”. Huge thanks to our entire team Jasmina Kapetanovic MacLaren Research Group Oxford for their support and hard work. Well done, Ben! sciencedirect.com/science/articl…

Annual lab dinner 2024. Vary proud to be a member of Robert MacLaren Research Group Oxford and Jasmina Jasmina Kapetanovic retina research lab.

On the 2nd of September at the University of Oxford’s Divinity School, we celebrated a milestone with Professor Robert McLaren’s lab MacLaren Research Group Oxford achieving an advancement in gene therapies for treating retinal eye diseases caused by a mutation in the CDHR1 gene.